Regenerative endoscopy for hard-to-treat Crohn's fistulas
Part of Digestive system clinical trials.
This trial tests a new, less invasive procedure called regenerative endoscopy to repair complex fistulas in people with Crohn's disease. It's for those who haven't gotten better with standard treatments like biologics or surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have Crohn's disease with a complex fistula near the anus that has multiple branches or internal openings.
- You have tried at least one strong medication (biologic) or had surgery for the fistula, and it didn't work.
- You have no abscess (pocket of infection) seen on a recent MRI.
- You have only mild or no inflammation in the rectum (proctitis) when checked with a scope.
- You have been on the same Crohn's medications for at least 8 weeks without changes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether injecting your own fat-derived cells combined with a skin graft can heal anal fistulas (abnormal passages near the anus) that didn't respond to or came back after a previous cell therapy study. You must have already participated in the ADICROHN-2 study.
This trial tests a treatment called endoscopic tSVF-EM therapy, which uses your own stem cells to help heal holes (fistulas) in your digestive tract. The procedure is done through a scope, and other tools like stents or clips may also be used. It aims to find out how well this treatment works and what factors affect recovery.
This trial tests if a special stem cell treatment (called DB-3Q bmMSC-EVs) can help heal fistulas caused by Crohn's disease. It's for people who have already tried other treatments and still have actively draining fistulas.
This trial tests whether injecting donated stem cells into complex anal fistulas can help heal them in people with Crohn's disease. You may qualify if you have a fistula that hasn't improved with standard treatments.
This trial tests a new approach that combines traditional Chinese medicine with stem cells to treat complex anal fistulas caused by Crohn's disease. It may help people whose Crohn's is not very active and who have not had major fistula surgery before.
This Phase 2 trial studies whether a local injection of fat-derived cells (made from your own tissue) can improve difficult Crohn’s disease fistulas around the anus. It’s designed for people whose Crohn’s fistulas have not responded to usual treatments.
Hear when a new Crohn Disease (CD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.